Caitong International Asset Management »

Emergent BioSolutions shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.1k 409 12.36
2025-06-30 $15k 2.4k 6.38

More positions owned by Caitong International Asset Management

Axsome Therapeutics (AXSM)
Satellogic Com Cl A (SATL)
American Bitcoin Corp. Com Cl A (ABTC)
Ultragenyx Pharmaceutical (RARE)
Redwire Corporation (RDW)
Corcept Therapeutics Incorporated (CORT)
Ur-energy (URG)
Dynavax Technologies Corp Com New (DVAX)
Arbe Robotics Ordinary Shares (ARBE)
T1 Energy Com New (TE)
Warby Parker Cl A Com (WRBY)
Petroleo Brasileiro Sa Petro Sp Adr Non Vtg (PBR.A)
Core Scientific (CORZ)
Planet Labs Pbc Com Cl A (PL)
Klarna Group SHS (KLAR)

View all positions for Caitong International Asset Management

Top funds holding Emergent BioSolutions

BlackRock
Oak Hill Advisors
Vanguard Group
State Street Corporation
American Century Companies
Dimensional Fund Advisors
Charles Schwab Investment Management
Palisade Capital Management
Geode Capital Management
Acadian Asset Management
Jain Global
LSV Asset Management
Connor, Clark & Lunn Investment Management
Prescott Group Capital Management
Marshall Wace

View all funds holding Emergent BioSolutions